Clinical Microbiology and Infection
Издатель: Elsevier · ISSN 1198-743X · 81 статей
- Risk of depression in individuals with syphilis: a population-based, nationwide matched cohort study in Denmark
- Upsetting the Hierarchy: Time to Update Clinical Trial Outcomes?
- Ten minutes after the injection: immediate systemic reactions to long-acting cabotegravir and rilpivirine
- Pathovars of Escherichia coli associated with diarrhoea – which, when and how to treat them
- Is a lower dose of trimethoprim sulfamethoxazole for Pneumocystis jirovecii pneumonia just as effective, but safer?
- Effect of immunomodulatory therapies on mortality in adults hospitalised with COVID-19 and non-COVID-19 community-acquired pneumonia: A systematic review and meta-analysis
- Towards a framework for immunisation programme resilience to vaccine confidence crises in the European Union: a narrative review
- Transplacental transfer efficiency and longitudinal dynamics of antibodies against RSV in early childhood: a paired mother-neonate cohort study in southern China
- Which patients with possible endocarditis should be treated as if the diagnosis were definite? An international modified Delphi study
- Finding the missing millions with tuberculosis
- Reinforced strategies versus standard pneumococcal vaccination regimen in patients with ANCA-associated vasculitides receiving rituximab therapy: A Multicenter Randomized Controlled Trial
- Artificial Intelligence for sepsis prediction: A review of real-world clinical implementation
- Re: ‘Hepatitis delta in Spain: a nationwide prospective characterization of active infection and liver disease severity’ by Alberola et al.
- Hepatitis B after switch to long-acting cabotegravir/rilpivirine: data from the SCohoLART cohort
- Optimising posaconazole dosing in paediatric patients: a population pharmacokinetic modelling and simulation study
- Which trial do we need? RSV booster vaccination in immunocompromised patients: Immunogenicity, safety and efficacy of booster vaccination strategies – Boost or bypass?
- Tailored Dosing Recommendations for Amikacin in Severely Ill Children: A Population Pharmacokinetic–Pharmacodynamic Evaluation using Cmax/MIC and AUC/MIC-based Indices
- Are systemic breakpoints appropriate for ocular infections?
- Machine learning for small-molecule antibiotics – discovery to pre-clinical optimization
- Model-informed dosing strategies for inhaled aminoglycosides in nosocomial pneumonia
- IDEntifying pAtients with suspicion of infection in the ED who have Low disease severity using midregional proadrenomedullin (MR-proADM) – A pragmatic pivotal randomised controlled trial